NCT03864510Completed
NAFLD in Diabetes Type 2 in Primary Care
Evaluating Prevalence and Severity of NAFLD In Primary Care
Source: ClinicalTrials.gov · Last updated 12 Dec 2025
Brief summary (registry, in English)
The EPSONIP (Evaluating Prevalence and Severity Of NAFLD In Primary care) trial is a longitudinal cohort study of patients with T2DM recruited from primary health care centers in Östergötland, Sweden. The latest MRI techniques will be used to quantify the amount of hepatic fat, inflammation, liver fibrosis and body composition. Each patient will be investigated twice with three years apart to determine patients with progressive disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 317 (actual)
- First submitted
- 12 Feb 2019
- Start date
- 1 Apr 2019
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Linkoeping University
- NCT number
- NCT03864510
What you commit to
- Study type: Observational
- Participants enrolled: 317
- From 1 Apr 2019 to the primary completion date, 1 Dec 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously diagnosed liver cirrhosis
- Previously known liver disease (other than fatty liver)
Other
- Contraindication to MR
- Alcohol dependance
Who the study is looking for
- Diabetes type 2
- Age 35-75 year
Age in the registry: 35 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ekholmen primary health care centre Coordinator of this site? Confirm its status | Linköping | Sweden | Unknown status |
| Åby primary health care centre Coordinator of this site? Confirm its status | Norrköping | Sweden | Unknown status |
Related publications
- Microvascular complications of type 2 diabetes with or without MASLD: the EPSOMIP study, a primary care cohort study.BMC Prim Care · 2025 · PMID 41219835
This page is information, not medical advice. Discuss any trial with your doctor.